| Date | Category | Article | Presenter |
|---|---|---|---|
| 2026-04-13 | COPD | Budesonide–formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids | |
| 2026-03-30 | COPD | Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry Subtypes by Smoking Status | |
| 2026-03-16 | Pleural Disease | Fast pleurodesis combining talc poudrage and indwelling pleural catheter for the management of recurrent malignant pleural effusions | |
| 2026-03-02 | COPD | Lancet | |
| 2026-02-16 | ILD | Mortality Outcomes and ACEI Use in Patients With IPF | Rani |
| 2026-01-12 | ILD | Family history of pulmonary fibrosis and outcomes. Chest 2021 | Nader |
| 2025-12-22 | COPD | Impact of Previous Occupational Exposure on Outcomes of COPD. J. Pers. Med. 2022, 12, 1592 | Nader |
| 2025-12-15 | ILD | Nintedanib in Progressive Fibrosing Interstitial Lung Disease - NEJM 2019 | Zero |
| 2025-11-17 | Infections | Inhaled Tobramycin for pseudomonas bronchiectasis | Foy |
| 2025-11-10 | Sarcoid | First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate NEJM 2025cf | Foy |
| 2025-10-27 | Pleural Disease | Intrapleural Use of TPA and DNase in pleural infection NEJM | Foy |
| 2025-10-13 | Pulmonary Vascular | Risk of recurrent venous thromboembolism and bleeding in acute subsegmental PEs Thrombosis Research 239 (2024) 109037 | Parsons |
| 2025-09-22 | Pulmonary Vascular | PEERLESS trial catheter based TPA vs thrombectomy | Santhi |
| 2025-09-08 | Pulmonary Vascular | Sotatercept in Patients with Pulmonary Arterial Hypertension NEJM 392;20 2025 | Santhi |
| 2025-08-25 | COPD | Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD; International Journal of Chronic Obstructive Pulmonary Disease 2025:20 2549–2560 | Hanalla |
| 2025-08-25 | COPD | Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD | Hanalla |
| 2025-08-11 | COPD | Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease | Hanalla |
| 2025-07-28 | COPD | Individual Risk Factors of PM2.5 Associated With Wintertime Mortality in Urban Patients With COPD Chest 2024 165 (44):825-835 | Zahedi |
| 2025-07-14 | wdwd | Anaerobic Antibiotic Coverage in Aspiration Pneumonia and the Associated Benefits and Harms Bai, Anthony D. et al. CHEST, Volume 166, Issue 1, 39 - 48 | Zahedi |
| 2025-06-23 | COPD | Maternal asthma is associated with increase drisk of perinatal mortality PLoS One 2018 May 18;13(5) | Jurayj |
| 2025-06-09 | ILD | Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis Respirology 2019 Aug;24(8):792-798. | Jurayj |
| 2025-05-12 | wdwd | fefefSivapalan et al Lancet Respir Med, 2019 | defefe |
| 2025-04-28 | COPD | Airway-Occluding Mucus Plugs and Mortality in Patients With COPD JAMA. 2023;329(21):1832-1839. | Khalifeh |
| 2025-04-14 | COPD | ensifentrine a novel phosphodiesterase-3 and 4 inhibitor for the treatment of COPD AJRCCM Vol208 (4):406 | Khalifeh |